Similar organisations to TYPE 1 DIABETES INTERNATIONAL
-
Medical Disciplines
-
847.
Pediatric Neurotransmitter Disease Association Inc
The PND association is a disease organization representing children and families who are affected by a pediatric neurotransmitter disease.
200
Farmingdale
-
Fund Raising and/or Fund Distribution
-
848.
Taylors Tale
Taylor's Tale is a public charity dedicated to the fight against CLN1 disease and other rare diseases.
3106
-
Senior Citizens' Housing, Retirement Communities
-
849.
Arlington Good Samaritan Housing Inc
TO PROVIDE LOW INCOME HOUSING FOR ELDERLY AND DISABLED PERSONS.
Sioux Falls
-
Urban, Community
-
850.
Invest Michigan
TO ENHANCE TECHNOLOGICIAL INNOVATION BY CREATING A NURTURING ENVIRONMENT DESIGNED TO ATTRACT START-UP AND EMERGING TECHNOLOGY-ORIENTED BUSINESSES IN MICHIGAN.
Northville
-
Health - General & Rehabilitative N.E.C.
-
851.
Methuselah Foundation
Accelerating biotechnologies to make 90 the new 50 by 2030 for anybody.
28557
Springfield
-
Patient Services�Entertainment, Recreation
-
852.
SCID Foundation
Disease awareness, support, education, and support of research for Severe Combined Immune Deficiency (SCID) The SCID Foundation is committed to increasing awareness, providing a safe environment for families to connect, advocating for the common concerns voiced by SCID patients or their families, and providing parent and family education for those affected by Severe Combined Immune Deficiency.
144
Glen Allen
-
Fund Raising and/or Fund Distribution
-
853.
Thunder Ride for Juvenile Diabetes CO
We ride for the day when diabetes is no longer the reason why Motorcycles Trikes Classic Cars and Convertibles Welcome to Join Us Saturday July 26th2025 See how you can directly help those in need.
La Crosse
-
Fund Raising and/or Fund Distribution
-
854.
Finding Ones Way The Brian M Langdon Found Inc
Brian M. Langdon Foundation Inc. Finding Ones Way Navigation Who we are.
465
Queensbury
-
Cancer Research
-
855.
TargetCancer Foundation Inc
TargetCancer Foundation (TCF) works to advance the development of more effective & personalized treatments for people with rare cancers.
2076
Cambridge